Neuromodulation of Memory in Aging
Indiana University · with National Institute on Aging (NIA) · NCT05460468
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–75 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 150
- US sites recruiting
- 1
- Study start
- March 28, 2024
- Record last updated
- August 11, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The proposed research will use closed-loop transcranial magnetic stimulation (TMS) based on individualized brain networks to establish parameters that can reliably control brain states. This will be tested in healthy aging and mild cognitive impairment (MCI) cohorts. The investigators will study network activation and neural oscillatory mechanisms underlying the network that regulates working memory and then target this network using closed-loop TMS to the Prefrontal Cortex. Investigators will measure the impact of TMS on working memory performance and task-based neural activity. The project will use brain stimulation and network modeling techniques to enhance working memory in healthy older adults and MCI and will demonstrate the value of closed-loop, network-guided TMS for future clinical applications.
Being studied: Transcranial Magnetic Stimulation
Conditions: Mild Cognitive Impairment; MCI
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- English Speaking
- Willing to provide consent
Exclusion Criteria
- History of any Axis I DSM-V disorder, excluding major depressive disorder or generalized anxiety disorders
- Current history of substance abuse or dependence (excluding nicotine)
- Intracranial implants (e.g. aneurysms clips, shunts, stimulators, cochlear implants, or electrodes), cardiac pacemakers, or vagus Nerve stimulation device
- Increased risk of seizure for any reason, including prior diagnosis of epilepsy, seizure disorder, increased intracranial pressure, or history of significant head trauma with loss of consciousness for ≥ 5 minutes.
- Neurological disorder including, but not limited to: space occupying brain lesion; any history of seizures, history of cerebrovascular accident; fainting, cerebral aneurysm, Dementia, Hungtington chorea; Multiple Sclerosis.
- Current use of medications known to lower the seizure threshold and/or affect working memory
Recruiting US locations
Duke University Hospital
Durham, NC 27710
Site contact: Simon Davis, PhD · 9196680437 · simon.davis@duke.edu
Study contacts (from the official record)
- Simon W Davis, PhD · 9196841243 · simon.davis@duke.edu
- Emily Finch, BA · 9196682842 · emily.finch@duke.edu
Similar studies in North Carolina
All neurology studies in North Carolina →- RecruitingHealthy volunteersPhase 1
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics And Pharmacodynamics of SIF001 in Healthy Subjects and in Epilepsy Patients
Suninflam Inc
- Location
- Charlotte, NC + 9 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteers
Aimovig Pregnancy Exposure Registry
Amgen
- Location
- Durham, NC
- Eligibility basics
- Ages 18–99 · Women only
- RecruitingPhase 1/Phase 2
A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome
Encoded Therapeutics
- Location
- Durham, NC + 9 other US sites
- Eligibility basics
- Ages 6 mo–17
- RecruitingPhase 3
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
TG Therapeutics, Inc.
- Location
- Charlotte, NC + 35 other US sites
- Eligibility basics
- Ages 18–65